Cervical Cancer Screening Clinical Trials

18 recruitingLast updated: June 18, 2026

There are 18 actively recruiting cervical cancer screening clinical trials across 11 countries. Studies span Not Applicable. Top locations include Ankara, Turkey (Türkiye), Atlanta, Georgia, United States, Bafoussam, Cameroon. Updated daily from ClinicalTrials.gov.


Cervical Cancer Screening Trials at a Glance

18 actively recruiting trials for cervical cancer screening are listed on ClinicalTrialsFinder across 6 cities in 11 countries. The largest study group is Not Applicable with 15 trials, with the heaviest enrollment activity in Ankara, Atlanta, and Bafoussam. Lead sponsors running cervical cancer screening studies include Institut de Recherche pour le Developpement, International Agency for Research on Cancer, and Ankara University.

Browse cervical cancer screening trials by phase

Treatments under study

About Cervical Cancer Screening Clinical Trials

Looking for clinical trials for Cervical Cancer Screening? There are currently 17 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Cervical Cancer Screening trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Cervical Cancer Screening clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 118 of 18 trials

Recruiting
Not Applicable

Single Visit Clinical Validation of ScreenFire, a Low-Cost HPV Test: Efficacy and Cost Effectiveness (Phase 2)

Cervical Cancer Screening
The Cleveland Clinic1,000 enrolled1 locationNCT07538050
Recruiting
Not Applicable

Emergency Department-based Cervical Cancer Screening Through Self-sampling

Cervical Cancer ScreeningHPVHPV Associated Cancers+2 more
University of Rochester200 enrolled1 locationNCT07345897
Recruiting
Not Applicable

Digital Telecytology for Triage of HPV-Positive Women in Cameroon

Human Papillomavirus InfectionCervical Cancer Screening MethodsCervical Intraepithelial Neoplasia Grade 2 (CIN2)
University Hospital, Geneva1,800 enrolled2 locationsNCT07550010
Recruiting
Not Applicable

Community Co-produced Action for Improved Access to Cervical Cancer Screening in Cameroon

Cervical Cancer Screening
Prof. Patrick Petignat800 enrolled1 locationNCT06640075
Recruiting

Cross-Cultural Adaptation and Psychometric Validation of the Cervical Cancer Screening Uptake Questionnaire (CCSTQ) in Turkish Women

HealthyCervical Cancer Screening
Ankara University215 enrolled1 locationNCT07451340
Recruiting
Not Applicable

Using Artificial Intelligence-based ChatBot to Improve Women's Participation to Cervical Cancer Screening Programme

Cervical CancerCervical Cancer Screening
International Agency for Research on Cancer3,000 enrolled1 locationNCT05286034
Recruiting
Not Applicable

Ameliorated Pap Tests and Cervical Cancer Screening Participation

Cervical Cancer ScreeningCervical Cancer Screening Methods
National Taiwan University Hospital248 enrolled5 locationsNCT06968871
Recruiting

Compliance to Cervical Cancer Chemoradiation Guidelines: A Multicentric Implementation Audit and Resource Assessment Initiative of National Cancer Grid of India

Gynecologic CancersCervical Cancer ScreeningChemoradiotherapy+1 more
Tata Memorial Hospital618 enrolled2 locationsNCT07290972
Recruiting
Not Applicable

Evaluation of the Q-Pad hrHPV Test System for Identifying Precancer

Cervical Cancer ScreeningHPV InfectionHPV+8 more
Qurasense450 enrolled4 locationsNCT07281599
Recruiting
Not Applicable

Accelerating Adoption of Patient-centered Cervical Cancer Screening and Treatment Linkage in Kenya

Cervical CancerCervical Cancer ScreeningHPV DNA
Kenyatta National Hospital1,980 enrolled1 locationNCT07050745
Recruiting
Not Applicable

Breast Cancer-Related Approach for Increasing Cervical Cancer Screening

Cervical Cancer Screening
Jessica Di Vincenzo Sormani4,500 enrolled1 locationNCT07171658
Recruiting
Not Applicable

Human Papillomavirus Self-sampling for Enhancing Cervical Screening During the War in Ukraine

Cervical CancerCervical Cancer ScreeningCervical Intraepithelial Neoplasia+1 more
Karolinska Institutet1,000 enrolled1 locationNCT07275333
Recruiting
Not Applicable

Optimization of Cervical Cancer Screening Strategies Among Women Living With HIV: Effectiveness and Implementation of Decentralized Approach Using a Mobile Team With HPV Testing in the Western Region of Cameroon

Cervical Cancer ScreeningHIV
Institut de Recherche pour le Developpement1,180 enrolled6 locationsNCT07181278
Recruiting
Not Applicable

Impact of a Single Versus Multiple Visits on the Cervical Cancer Screening Completeness, Feasibility and Acceptability Among Women Living With HIV in Cameroon

Cervical Cancer ScreeningHIV
Institut de Recherche pour le Developpement1,422 enrolled1 locationNCT07177170
Recruiting
Not Applicable

Comparing Effectiveness of Physician-assisted Versus Self-assisted Pap Smear Collection

Cervical Cancer Screening
Morehouse School of Medicine200 enrolled1 locationNCT06229275
Recruiting

Project CONTINUITY: Promoting Evidence-Based Cancer Screening Among Underserved Women

Cervical Cancer Screening Methods
University of Florida800 enrolled1 locationNCT05390567
Recruiting
Not Applicable

St. Joseph's HPV Self-sampling: Offering a Self-sampling Option in Clinic

Cervical Cancer Screening
Milton S. Hershey Medical Center50 enrolled1 locationNCT05092022
Recruiting
Not Applicable

Characteristics of Human Papillomavirus (HPV) Infections and HPV Vaccine Attitudes Among Slovenian Women After the Introduction of HPV Vaccination

Cervical Cancer ScreeningVaccination Uptake
University Medical Centre Ljubljana500 enrolled1 locationNCT06995157